Stocks
Neurocrine Biosciences (NBIX) P/E US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 266.2 | 21.9 | 89.9 | 74.1 | 51.6 | 29.7 | ||
| Changes by years, y/y, % | -13% | -92% | +310% | -18% | -30% | -29.9% | |||
Neurocrine Biosciences. P/E
Neurocrine Biosciences. P/E, changes, %
Neurocrine Biosciences (NBIX) P/E US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/E | ? | 57.7 | 51.9 | 37.2 | 40.9 | 30.2 | 29.7 | |
| Changes by years, y/y, % | -67% | -30% | -76% | -22% | -48% | |||
| Changes by quarters, q/q, % | +11% | -10% | -28% | +10% | -26% | |||
